Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser: a Randomized Controlled Two-parallel Group Multicenter Trial With Blinding Evaluation - Trial NCT05916963
Access comprehensive clinical trial information for NCT05916963 through Pure Global AI's free database. This Phase 3 trial is sponsored by University Hospital, Tours and is currently Not yet recruiting. The study focuses on Kidney Stone. Target enrollment is 374 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University Hospital, Tours
Timeline & Enrollment
Phase 3
Oct 15, 2023
Jan 15, 2026
Primary Outcome
Stone free rate
Summary
In view of the positive results of the numerous studies conducted on forced diuresis after
 extra-corporeal lithotripsy, we chose to evaluate forced diuresis by injection of Furosemide
 associated with intravenous hydration, which has never before been the subject of a specific
 analysis.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05916963
Non-Device Trial